000 02054cam  2200325zi 4500
0019.937240
003CaOODSP
00520240611110605
006m     o  d f      
007cr |n|||||||||
008240419e20041214onc     ob   f|0| 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH14-609/2004E-PDF
24500|aSummary report of the inspections of clinical trials conducted in 2003/2004 / |cHealth Products and Food Branch Inspectorate.
264 1|a[Ottawa] : |bHealth Canada, Health Products and Food Branch Inspectorate, |cDecember 14, 2004.
300 |a1 online resource (20 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Rapport sommaire des inspections d'essais cliniques réalisées en 2003 et 2004.
500 |aCover title.
504 |aIncludes bibliographical references.
520 |a"This document provides the results and analysis of the findings of inspections of clinical trials conducted by the Health Products and Food Branch Inspectorate (Inspectorate) in 2003/2004. This is the second annual report of inspections of clinical trials, and is intended to assess compliance of the conduct of clinical trials under the purview of Division 5 of the Food and Drug Regulations “Drugs for clinical trials involving human subjects” "--Executive Summary, page 3.
650 0|aClinical trials|zCanada.
7101 |aCanada.|bHealth Canada. |bHealth Products and Food Branch Inspectorate, |eissuing body.
77508|tRapport sommaire des inspections d'essais cliniques réalisées en 2003 et 2004 / |w(CaOODSP)9.937241
85640|qPDF|s143 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-609-2004-eng.pdf
85641|qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-clinical-practices/reports/summary-report-inspections-clinical-trials-conducted-2003-2004.html